Bio-Rad Laboratories, Inc.
Corporate Profile
Bio-Rad Laboratories, Inc. stands as a titan in the Life Science sector. With a valuation of $10.6 Billion, the company employs over 8,900 people worldwide. Headquartered in Hercules, California, USA, it continues to drive innovation and maintain its market dominance.
Strategy, capital, and competitive context
Bio-Rad Laboratories, Inc. operates in Life Science with headquarters in Hercules, California, USA (founded 1952). The headline market cap of $10.6B reflects how public markets are pricing the equity right now; it can swing on rates, sector sentiment, and a handful of product cycles. Revenue of not modeled on this page is shown as a coarse annualized snapshot for orientation—always compare to the latest audited financials.
From a capital-allocation lens, we watch how reinvestment (R&D, capex, M&A) maps to returns and balance-sheet flexibility. A wide gap between revenue growth and multiple expansion often signals shifting expectations about moat durability, regulation, or geographic mix. Where we publish charts, they are built from the site's structured history fields and may be interpolated when filings are sparse—see methodology for limitations.
Competitive benchmarking on this page uses linked peers when available; treat it as a starting point for industry mapping, not a buy/sell screen. Ticker BIO is displayed for convenience; verify exchange codes before trading.
Editorial note: this section is authored in-house to explain how we connect metrics to meaning. It is updated when material fundamentals change; report issues on corrections.
Financial History
Verified multi-year history for Bio-Rad Laboratories, Inc. is not yet available in our database. We publish charts only from documented data points—not synthetic estimates.
Read our methodologyIn-Depth Analysis
Data Sources & Methodology
Figures for Bio-Rad Laboratories, Inc. are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.